HDAP Meeting / Conference Call
HDAP provides credible, independent and expert scientific advice to board staff in conducting scientific reviews of information submitted by patentees.
Form 1 – Medicine Identification Sheet – due January 10, 2019
One copy of product monograph or information similar to that included in a product monograph (if product has not yet been approved for sale in Canada)
One electronic copy of patentee submission – due February 14, 2019
- Specialty Therapies and Biosimilars Congress
- Jan 22 2020 - Jan 24 2020
- All of the day